Added-Value Generics

Chlorhexidine & Antiseptics

ADDED-VALUE Generics

API

FDF

HPAPI

CHLORHEXIDINE & ANTISEPTICS

API

FDF

Biocide

Pharma

Medichem

WHY MEDICHEM CAN HELP YOU

Medichem is a vertically integrated pharmaceutical company. We specialize in the development and manufacture of APIs and FDFs for the global generics industry.

Our portfolio includes around 45 APIs and 20 FDFs, and we are a world leader in Chlorhexidine products. With nearly half a century of industry experience, we guarantee the highest standards of quality, operational excellence and respect for the environment.

Medichem is headquartered in Spain, with a team of around 400 talented individuals in locations including the USA, Malta and China. We serve over 600 corporate customers in more than 60 countries worldwide.

Marketing Authorizations

900

Marketing Authorizations

APIs

42

APIs

Products in
development

16

Products in
development

Years in
operation

50

Years in
operation

Patents and patent applications

80

Patents and patent applications


OUR EXPERTISE AT YOUR SERVICE

expertise

For half a century, Medichem has been at the forefront of innovation and as such has developed 70 value-added drug products as well as a wide range of services, ranging from R&D to contract manufacturing and licensing.

INNOVATION AND EXCELLENCE
Innovation
and Excellence
MANUFACTURING SOLUTIONS
Manufacturing
Solutions
REGULATORY & QUALITY
REGULATORY AND QUALITY SUPPORT DURING THE REGISTRATION AND DEVELOPMENT PROCESS
INTELLECTUAL PROPERTY
FULL GUIDANCE ON INTELLECTUAL PROPERTY
CONTRACT SERVICES
TAILOR-MADE SOLUTIONS FOR EACH CUSTOMER


Worldwide Presence

MALTA

Hal Far

CHINA

Nanjing

USA

New Jersey

SPAIN

Barcelona

SPAIN

Girona

Worldwide Presence

Medichem Worldwide Presence

Medichem Cares

Customer <br> Stories
Environmental  <br>Sustainability
Community <br>Giving

NEWSROOM

Prucalopride, launch in Europe
10/06/21

Prucalopride, launch in Europe

We are pleased to announce that this week we received the confirmation of the launch of Prucalopride in Europe. This is a 100% verti...

Read More
Quality Indicators from an API manufacturer perspective
01/06/21

Quality Indicators from an API manufacturer perspective

Ms. Mariona Senis, Quality Director of Medichem, S.A., participated as a guest speaker in the training program on Indicators of the ...

Read More
Global Recycling Day 17th May
17/05/21

Global Recycling Day 17th May

Find out the way Medichem contributes to Global Sustainability.

Read More
World Day for Safety and Health at Work
28/04/21

World Day for Safety and Health at Work

Many workshops organized on 28th April at different Medichem sites to help improve health and safety at work: respiratory protection...

Read More
Apixaban
05/03/21

Apixaban

We are pleased to announce that the DCP Marketing Authorization related to Medichem Apixaban 2.5mg and 5mg film-coated tablets w...

Read More
Medicines for Europe
04/03/21

Medicines for Europe

Today, February 26th, Elisabeth Stampa, CEO of Medichem, has participated in the High-level launch event of the EU structured dialog...

Read More
Medicines for Europe’s press release
03/03/21

Medicines for Europe’s press release

We would like to share Medicines for Europe’s press release on the EU dialogue organized by the European Commission last 26th Februa...

Read More
New Site!
16/01/21

New Site!

Our shiny new site is now live! Check it out and discover: * Our customers' stories and how we go “beyond the pill” by providing un...

Read More
Season’s Greetings from all of us at Medichem!
23/12/20

Season’s Greetings from all of us at Medichem!

This year has certainly been extraordinary and we would like to express our deep gratitude for your trust. We wish you an enjoyable ho...

Read More
Medichem is committed to providing products with added value while minimizing its environmental impact
24/11/20

Medichem is committed to providing products with added value while minimizing its environmental i...

We strive to reach the United Nations Sustainable Development Goals and integrate them into our daily operations. This month, we would...

Read More